New Urine Test Improves Bladder Cancer Diagnosis and Treatment Selection

Researchers at Stanford Medicine and the VA Palo Alto Health Care System have developed a novel urine test for bladder cancer. This test offers more accurate diagnosis than current standard methods and can predict which patients will best respond to immunotherapy versus chemotherapy, while also confirming treatment efficacy. This advancement paves the way for more personalized and effective bladder cancer care.